Antibiotic Therapy for Acute Diarrhea and Nausea
Most patients with acute diarrhea should NOT receive antibiotics, as the illness is typically self-limited and antibiotics add unnecessary risk of adverse effects and antimicrobial resistance. 1
When to Give Antibiotics
Immunocompetent Adults and Children
Do NOT give empiric antibiotics for acute watery diarrhea without recent international travel. 1 The exception is for immunocompromised patients or ill-appearing young infants. 1
Give empiric antibiotics for bloody diarrhea ONLY in these specific scenarios: 1
- Infants <3 months of age with suspected bacterial etiology 1
- Ill patients with documented fever in a medical setting, abdominal pain, bloody diarrhea, and bacillary dysentery (frequent scant bloody stools, fever, abdominal cramps, tenesmus) presumptively due to Shigella 1
- Recent international travelers with body temperature ≥38.5°C and/or signs of sepsis 1
Immunocompromised Patients
Empiric antibacterial treatment should be strongly considered in immunocompromised patients with severe illness and bloody diarrhea. 1 This population is at higher risk for complications and disseminated disease. 2
For immunocompromised patients with otherwise uncomplicated Campylobacter gastroenteritis, treatment is reasonable despite lack of strong evidence, as fatal infections are more common in severely immunocompromised hosts. 1
Traveler's Diarrhea Context
For moderate to severe traveler's diarrhea (distressing or incapacitating symptoms), antibiotics are indicated. 3
Azithromycin is the preferred first-line agent: 3
- Single 1-gram dose OR
- 500 mg daily for 3 days
Regional considerations are critical: 3
- In Southeast Asia, azithromycin is clearly superior due to fluoroquinolone resistance exceeding 85-90% for Campylobacter 3
- Fluoroquinolones may be considered for severe non-dysenteric cases ONLY in regions with low resistance (<15%) 3
Antibiotic Selection
First-Line Empiric Therapy
For adults with bloody diarrhea meeting treatment criteria: 1
- Fluoroquinolone (ciprofloxacin) OR azithromycin, depending on local susceptibility patterns and travel history 1
- Ciprofloxacin 500 mg every 12 hours for 5-7 days for infectious diarrhea 4
For children requiring empiric therapy: 1
- Third-generation cephalosporin for infants <3 months or those with neurologic involvement 1
- Azithromycin for others, depending on local susceptibility and travel history 1
Critical Contraindication
AVOID antibiotics in patients with STEC O157 and other STEC producing Shiga toxin 2 (or if toxin genotype unknown), as antimicrobial therapy may increase risk of hemolytic uremic syndrome. 1 For non-O157 STEC that do not produce Shiga toxin 2, the evidence is insufficient to recommend for or against treatment. 1
Duration and Modification
Antimicrobial treatment should be modified or discontinued when a clinically plausible organism is identified. 1 This allows for targeted therapy and avoids unnecessary broad-spectrum coverage.
For infectious diarrhea, the usual duration is 5-7 days when antibiotics are indicated. 4
Common Pitfalls to Avoid
Do not use antimotility agents (loperamide) in suspected inflammatory diarrhea or diarrhea with fever, as this may worsen outcomes and increase risk of toxic megacolon. 1 Loperamide should be avoided at any age in these scenarios. 1
Do not give antibiotics to asymptomatic contacts of people with acute or persistent diarrhea, except asymptomatic carriers of Salmonella typhi who may be treated empirically to reduce transmission. 1
Avoid routine empiric antibiotics in persistent watery diarrhea lasting ≥14 days, as noninfectious causes (inflammatory bowel disease, irritable bowel syndrome, lactose intolerance) become more likely. 1
Special Populations
For immunocompromised patients with Clostridioides difficile colitis, specific testing should be performed in the event of diarrhea with or without acute abdomen. 1 Treatment should include appropriate antibiotics with early surgical consultation if systemic toxicity develops. 1
Pregnant women and children should receive azithromycin as the preferred agent when antibiotics are indicated. 3